+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NOVATEOR NOVATEOR

Novateor Research Laboratories Share Price

₹43.00 +5 (13.16%)
New 52W High today

26 Oct, 2026 4:01 PM (IST)

Novateor Research Laboratories live price: ₹43.00. It opened at ₹43 vs previous close ₹38; intraday high/low: ₹43/₹43. The 50 & 200 DMA stand at ₹34.90/₹30.40.

Novateor Research Laboratories Performance

  • Today's Low
  • ₹43
  • Today's High
  • ₹43
  • 52 Week Low
  • ₹20
  • 52 Week High
  • ₹43
  • Open Price₹43
  • Previous Close₹38
  • Volume3,000
  • 50 DMA₹34.90
  • 100 DMA₹34.90
  • 200 DMA₹30.40

Novateor Research Laboratories Chart

Investment Returns

  • Over 1 Month + 14.67%
  • Over 3 Month + 30.9%
  • Over 6 Month + 37.78%
  • Over 1 Year + 65.38%

Smart Investing Starts Here Start SIP with Novateor Research Laboratories for Steady Growth!

Invest Now

Novateor Research Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 257.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 26
  • P/B Ratio
  • 2.3
  • Average True Range
  • 3.1
  • EPS
  • 0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.7
  • RSI
  • 63.87
  • MFI
  • 67.45

Latest Stock News Updates

Novateor Research Laboratories Ltd - 542771 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

The company has entered into Supply agreement with Pidilite Industries Limited as on October 16, 2026 on an exclusive basis for the development, manufacture, packing and supply of Aligner Cleaning Form and Tooth Brightening Strips to be supplied exclusively to Pidilite Industries Limited

Novateor Research Laboratories Ltd - 542771 - Non Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015

Non Applicability of disclosure of Related party transactions under Regulation 23(9) of SEBI (LODR) Regulations, 2015

Novateor Research Laboratories Ltd - 542771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2028 for the quarter ended September 30, 2026

Novateor Research Laboratories Financials

Novateor Research Laboratories Technicals

EMA & SMA

Current Price
₹43.00
+ 5 (13.16%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹34.40
  • 50 Day
  • ₹34.90
  • 100 Day
  • ₹34.90
  • 200 Day
  • ₹30.40

Resistance and Support

43 Pivot Speed
  • R3 43.00
  • R2 43.00
  • R1 43.00
  • S1 43.00
  • S2 43.00
  • S3 43.00

Novateor Research Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-03 A.G.M.
2026-05-30 Audited Results
2025-11-14 Half Yearly Results
2025-09-03 A.G.M.
2025-05-30 Audited Results

Novateor Research Laboratories Shareholding Pattern

50.75%
49.24%
0%

About Novateor Research Laboratories

Novateor Research Laboratories is an Indian research-focused public company specializing in the development, manufacturing, and marketing of novel oral care and personal care products View More
  • NSE Symbol
  • NOVATEOR
  • BSE Symbol
  • 542771
  • Executive Director,Managing Director,Chief Financial Officer
  • Navdeep Subhashbhai Mehta
  • ISIN
  • INE08JY01013

Similar Stocks to Novateor Research Laboratories

Novateor Research Laboratories FAQs

Novateor Research Laboratories share price is ₹43 As on 30 October, 2026 | 12:02

The Market Cap of Novateor Research Laboratories is ₹26 Cr As on 30 October, 2026 | 12:02

The P/E ratio of Novateor Research Laboratories is 257.2 As on 30 October, 2026 | 12:02

The PB ratio of Novateor Research Laboratories is 2.3 As on 30 October, 2026 | 12:02

The 52 week High & Low of Novateor Research Laboratories is ₹43/₹20.1 respectively As on 30 October, 2026 | 12:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23